ZYBERNO
Stock Report
Updated Sep 1, 2026

Q/C Technologies, Inc. (QCLS)

Healthcare • NASDAQ

$2.32

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
Q/C Technologies, Inc. (QCLS) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-90.9%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.05x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-65.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Q/C Technologies, Inc. (QCLS) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.32
Market Cap:$19.11M

Valuation Multiples (2)

P/B Ratio:1.19x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$19.17M

Price Action & Momentum (3)

Momentum Percentile:4 / 100
% of 52-Week High:26.0%
B. Profitability Assessment

Return Metrics (5)

ROA:-47.5%
Reinvestment Rate:-16.2%
Fundamental Growth Rate (g):10.6%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$323.84
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-48.9%
Latest Earnings Filed:2026-08-12
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.29x
Quick Ratio:3.29x
Cash Ratio:0.09x

Leverage Analysis (3)

Debt To Equity Ttm:0.05x
Debt-to-Equity Ratio:0.05x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:8,175,648.00
Cash And Cash Equivalents:307,612.00
Long Term Debt:$226.01K
Net Debt:$63.56K
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$14.15M

Bottom Line Performance (3)

-$16.57M
Income Before Tax:-$16.57M
Ebitda Ttm:-14,114,773.00

Operating Expenses (5)

Operating Expenses:3,612,737.00
R And D Expense:1,799,523.00
Sga Expense:4,070,142.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$22.87M
Current Assets:$11.74M
Ppe Net:140,868.00
Goodwill:10,498,539.00
Intangible Assets:$14.09M

Liability Structure (4)

Total Liabilities:6,774,857.00
Current Liabilities:3,565,470.00
Long Term Debt:$226.01K
Short Term Debt:$145.16K

Equity & Capital (3)

Equity:$16.09M
Retained Earnings:-$152.19M
Common Stock:1,250,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:1,337,625.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:2,373,655.00
C. Cash Flow Analysis

Operating Activities (2)

-$9.71M-$9.78M

Investment Activities (2)

Investing Cash Flow:$2.97M
Capital Expenditures Ttm:65,584.00

Financing Activities (3)

Financing Cash Flow:$453.93K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:6,700,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-9.10
-$9.10
Earnings Per Share Ttm:-$2.01

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$1.10

Book Value & Capital (2)

Book Value Per Share:$1.95
Cash Per Share:0.04

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:-16.2%
Fundamental Growth Rate (g):10.6%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-3.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:QCLS
Company Name:Q/C Technologies, Inc.
Sector:Healthcare
Industry:Medical Diagnostics
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.24M
Shares Outstanding Basic:8.24M
Shares Outstanding Diluted:8.24M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 08:16:08 UTC
Data Timestamp:2026-08-20T21:07:37.046413
Scroll to Top